These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38828798)

  • 1. Solid Lipid Nanoparticles for Pulmonary Delivery of Biopharmaceuticals: A Review of Opportunities, Challenges, and Delivery Applications.
    Alwani S; Wasan EK; Badea I
    Mol Pharm; 2024 Jul; 21(7):3084-3102. PubMed ID: 38828798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid nanoparticles for the delivery of biopharmaceuticals.
    Silva AC; Amaral MH; Lobo JM; Lopes CM
    Curr Pharm Biotechnol; 2015; 16(4):291-302. PubMed ID: 25601601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid lipid nanoparticles and their application in the treatment of bacterial infectious diseases.
    Arabestani MR; Bigham A; Kamarehei F; Dini M; Gorjikhah F; Shariati A; Hosseini SM
    Biomed Pharmacother; 2024 May; 174():116433. PubMed ID: 38508079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid lipid nanocarriers in drug delivery: characterization and design.
    Mu H; Holm R
    Expert Opin Drug Deliv; 2018 Aug; 15(8):771-785. PubMed ID: 30064267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in topical delivery of proteins and peptides mediated by soft matter nanocarriers.
    Witting M; Obst K; Friess W; Hedtrich S
    Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1355-69. PubMed ID: 25687276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging trends in pulmonary delivery of biopharmaceuticals.
    Kunde SS; Ghosh R; Wairkar S
    Drug Discov Today; 2022 May; 27(5):1474-1482. PubMed ID: 35143963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid lipid nanoparticles and nanostructured lipid carriers: a review of the methods of manufacture and routes of administration.
    Akbari J; Saeedi M; Ahmadi F; Hashemi SMH; Babaei A; Yaddollahi S; Rostamkalaei SS; Asare-Addo K; Nokhodchi A
    Pharm Dev Technol; 2022 Jun; 27(5):525-544. PubMed ID: 35635506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid-based carriers: manufacturing and applications for pulmonary route.
    Jaafar-Maalej C; Elaissari A; Fessi H
    Expert Opin Drug Deliv; 2012 Sep; 9(9):1111-27. PubMed ID: 22724618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives on cutting-edge nanoparticulate drug delivery technologies based on lipids and their applications.
    Maddiboyina B; Ramaiah ; Nakkala RK; Roy H
    Chem Biol Drug Des; 2023 Aug; 102(2):377-394. PubMed ID: 36916008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic-free nanotherapeutics: ultra-small, mucus-penetrating solid lipid nanoparticles enhance the pulmonary delivery and anti-virulence efficacy of novel quorum sensing inhibitors.
    Nafee N; Husari A; Maurer CK; Lu C; de Rossi C; Steinbach A; Hartmann RW; Lehr CM; Schneider M
    J Control Release; 2014 Oct; 192():131-40. PubMed ID: 24997276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid Lipid Nanoparticles: Applications and Prospects in Cancer Treatment.
    Sivadasan D; Ramakrishnan K; Mahendran J; Ranganathan H; Karuppaiah A; Rahman H
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid nanocarriers: influence of lipids on product development and pharmacokinetics.
    Pathak K; Keshri L; Shah M
    Crit Rev Ther Drug Carrier Syst; 2011; 28(4):357-93. PubMed ID: 21967401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulating SLN and NLC as Innovative Drug Delivery Systems for Non-Invasive Routes of Drug Administration.
    Fonseca-Santos B; Silva PB; Rigon RB; Sato MR; Chorilli M
    Curr Med Chem; 2020; 27(22):3623-3656. PubMed ID: 31232233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid lipid nanoparticles: a versatile approach for controlled release and targeted drug delivery.
    Munir M; Zaman M; Waqar MA; Khan MA; Alvi MN
    J Liposome Res; 2024 Jun; 34(2):335-348. PubMed ID: 37840238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the lung clearance kinetics of solid lipid nanoparticles and liposomes by following the
    Haque S; Whittaker M; McIntosh MP; Pouton CW; Phipps S; Kaminskas LM
    Eur J Pharm Biopharm; 2018 Apr; 125():1-12. PubMed ID: 29309835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid lipid nanoparticles: promising therapeutic nanocarriers for drug delivery.
    Thukral DK; Dumoga S; Mishra AK
    Curr Drug Deliv; 2014; 11(6):771-91. PubMed ID: 25469779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
    Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
    Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid lipid nanoparticles for sustained pulmonary delivery of Yuxingcao essential oil: Preparation, characterization and in vivo evaluation.
    Zhao Y; Chang YX; Hu X; Liu CY; Quan LH; Liao YH
    Int J Pharm; 2017 Jan; 516(1-2):364-371. PubMed ID: 27884712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic profiling of the release kinetics of siRNA from lipidoid-polymer hybrid nanoparticles in vitro and in vivo after pulmonary administration.
    Thanki K; van Eetvelde D; Geyer A; Fraire J; Hendrix R; Van Eygen H; Putteman E; Sami H; de Souza Carvalho-Wodarz C; Franzyk H; Nielsen HM; Braeckmans K; Lehr CM; Ogris M; Foged C
    J Control Release; 2019 Sep; 310():82-93. PubMed ID: 31398360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances and patents on solid lipid nanoparticles.
    Sawant KK; Dodiya SS
    Recent Pat Drug Deliv Formul; 2008; 2(2):120-35. PubMed ID: 19075903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.